BR0011427A - Analgésicos tricìclicos - Google Patents

Analgésicos tricìclicos

Info

Publication number
BR0011427A
BR0011427A BR0011427-8A BR0011427A BR0011427A BR 0011427 A BR0011427 A BR 0011427A BR 0011427 A BR0011427 A BR 0011427A BR 0011427 A BR0011427 A BR 0011427A
Authority
BR
Brazil
Prior art keywords
alkyl
hydrogen
cycloalkyl
alkenyl
hydroxy
Prior art date
Application number
BR0011427-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Alain Calvet
Henri Jacobelli
Jocelyne Puaud
Francois J Roman
Jacques Hamon
Agnes Grouhel
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0011427A publication Critical patent/BR0011427A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR0011427-8A 1999-06-07 2000-06-07 Analgésicos tricìclicos BR0011427A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13786899P 1999-06-07 1999-06-07
PCT/EP2000/005783 WO2000075116A2 (en) 1999-06-07 2000-06-07 Tricyclic analgesics

Publications (1)

Publication Number Publication Date
BR0011427A true BR0011427A (pt) 2002-03-26

Family

ID=22479397

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011427-8A BR0011427A (pt) 1999-06-07 2000-06-07 Analgésicos tricìclicos

Country Status (21)

Country Link
EP (1) EP1235808A2 (es)
JP (1) JP2003513006A (es)
KR (1) KR20020010923A (es)
CN (1) CN1635998A (es)
AP (1) AP2001002356A0 (es)
AU (1) AU6428400A (es)
BG (1) BG106162A (es)
BR (1) BR0011427A (es)
CA (1) CA2376076A1 (es)
EA (1) EA200101117A1 (es)
HR (1) HRP20010913A2 (es)
HU (1) HUP0203317A2 (es)
IL (1) IL146755A0 (es)
IS (1) IS6175A (es)
MA (1) MA26795A1 (es)
MX (1) MXPA01012694A (es)
NO (1) NO20015966L (es)
PL (1) PL357340A1 (es)
SK (1) SK17512001A3 (es)
TR (1) TR200103531T2 (es)
WO (1) WO2000075116A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
FR2915099B1 (fr) * 2007-04-19 2009-06-05 Sanofi Aventis Sa Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
WO2012106499A1 (en) * 2011-02-02 2012-08-09 Vertex Pharmaceuticals Incorporated Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
CN115872873A (zh) * 2022-12-29 2023-03-31 上海泰坦科技股份有限公司 一种双（2-溴乙基）胺氢溴酸盐的重结晶纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917069D0 (en) * 1989-07-26 1989-09-13 Merck Sharp & Dohme Therapeutic agents
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
DK0681571T3 (da) * 1993-01-28 1998-11-23 Merck & Co Inc Spiro-substituerede azacykliske forbindelser som tachykininreceptorantagonister
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
WO1998025604A1 (en) * 1996-12-13 1998-06-18 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
US6013644A (en) * 1997-12-12 2000-01-11 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity

Also Published As

Publication number Publication date
IS6175A (is) 2001-11-23
WO2000075116A2 (en) 2000-12-14
MA26795A1 (fr) 2004-12-20
CA2376076A1 (en) 2000-12-14
HRP20010913A2 (en) 2003-04-30
AU6428400A (en) 2000-12-28
AP2001002356A0 (en) 2001-12-31
MXPA01012694A (es) 2003-10-15
CN1635998A (zh) 2005-07-06
HUP0203317A2 (hu) 2003-02-28
NO20015966D0 (no) 2001-12-06
NO20015966L (no) 2001-12-06
TR200103531T2 (tr) 2002-06-21
JP2003513006A (ja) 2003-04-08
EA200101117A1 (ru) 2002-06-27
KR20020010923A (ko) 2002-02-06
BG106162A (bg) 2002-05-31
SK17512001A3 (sk) 2002-11-06
WO2000075116A3 (en) 2002-07-04
PL357340A1 (en) 2004-07-26
EP1235808A2 (en) 2002-09-04
IL146755A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
BR9813360A (pt) Derivados de ácido hidroxâmico como inibidores de metaloprotease de matriz (mmp)
BR9812095A (pt) Compostos de indol como inibidores de cox-2
BR9913592A (pt) Compostos, processo de preparação dos compostos, e, composições farmacêuticas
BR9811521A (pt) Composição para tratar ou impedir a glomerulopatia
BR9907300A (pt) Inibidores do fator xa oxoaza-heterociclila substituìdos
AU636330B2 (en) N-phenyl-n-(4-piperidinyl)amides useful as analgesics
BR9812699A (pt) Derivados de benzamidina
BR0002518A (pt) Derivados de 4-arilpiperidina para o tratamento de prurido
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
PE20050012A1 (es) Compuestos de benzopirano como inhibidores de la ciclooxigenasa-2
BR0100234A (pt) Compostos de piperidina-4-sulfonamida, processo para a sua preparação e composições farmacêuticas contendo os mesmos
BRPI0413013A (pt) composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças
EE04496B1 (et) Tetrahüdro-gamma-karboliinid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad kompositsioonid
BR0314844A (pt) Novo composto
BR0011427A (pt) Analgésicos tricìclicos
FI844333A0 (fi) 11-substituerade 5h,11h-pyrrolo/2,1-c/ /1,4/benzoxazepiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI895046A0 (fi) 4-amino-3-acylkinolinderivat samt deras anvaendning saosom inhibitorer av sekretion av matsmaeltningsvaetskor.
NO934483L (no) Hydroksyamidin-derivater
DK0952159T3 (da) Anvendelse af phenylhydrazonderivater som antiinflammatoriske eller analgetiske midler
BR0015401A (pt) [(indol-3-il)-cicloalquil]-3-azetidinas substituìdas para o tratamento de distúrbios do sistema nervoso central
AR016594A1 (es) DERIVADOS DE 3,4,5,7-TETRAHIDRO-PIRROLO[3',4':4,5]TIENO[2,3-d]PIRIMIDINA 3-SUSTITUIDOS Y SU USO PARA LA PREPARACION DE COMPOSICIONES FARMACEUTICAS
BR9907497A (pt) Compostos de imidazolina, um processo para seu preparo e compostos farmacêuticos contendo os mesmos
BR0207966A (pt) Composição farmacêutica contendo derivados 1,3-tiazina
BR0002516A (pt) Compostos úteis em terapia
PE99399A1 (es) Compuesto farmaceutico derivado de tiadiazolo quinoleina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O, 8O E 9O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.